Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 05, 2015 10:57 AM ET

Healthcare Providers and Services

Company Overview of Ameritox, Ltd.

Company Overview

Ameritox, Ltd., doing business as Ameritox Limited Partnership, develops pain medication monitoring solutions for pain management. It offers laboratory services and practice management tools; Rx GuardianCD, a urine drug monitoring solution; Rx Guardian INSIGHT Report, which provides physicians with a view of their chronic pain patient’s medication monitoring results; and Rx Guardian results report that provides information available on patients’ pain medication use in easy-to-read format. The company also provides clinical staff training and support, results interpretation and support, and online services; Risperdal, a method to help assess medication adherence in behavioral health patients ...

300 East Lombard Street

Suite 1610

Baltimore, MD 21202

United States

Founded in 1996

Phone:

443-220-0115

Fax:

443-220-0122

Key Executives for Ameritox, Ltd.

Chief Executive Officer
Age: 48
Chief Financial Officer and Senior Vice President
Chief Operating Officer
Age: 49
Chief Laboratory Officer and Senior Vice President
Age: 52
Senior Vice President of Managed Care
Age: 67
Compensation as of Fiscal Year 2015.

Ameritox, Ltd. Key Developments

Ingenuity Health Expands Reference Database to Help Assess Medication Adherence in Those with Serious Mental Illness

Ingenuity Health, a service of Ameritox Ltd. expanded its comprehensive reference database that helps clinicians assess medication adherence among patients with Serious Mental Illness. Ingenuity Health has developed a method to help assess adherence in patients prescribed the antipsychotic drug lurasidone, marketed under the brand name Latuda®. The reference database provides behavioral health clinicians help in addressing the ongoing problem of medication non-adherence in those with SMI.

Ameritox's Ingenuity Health Introduces Method to Help Assess Medication Adherence in Patients Prescribed Risperdal

Ameritox announced that it has launched a method to help assess medication adherence in behavioral health patients prescribed the antipsychotic drug risperidone (tradename, Risperdal). This new method marks a critical step toward establishing a comprehensive reference database for commonly prescribed antipsychotic medications, providing behavioral health clinicians help in addressing the acute problem of medication non-adherence in those with serious mental illness. The company’s Ingenuity Health service conducted research that allows it to provide additional information about whether a patient may be taking risperidone in accordance with his or her prescribed treatment plan. By comparing normalized urine drug results against the results of patients clinically assessed as adherent, behavioral health centers and medical professionals will have more information as they manage and treat patients prescribed risperidone. Risperidone now joins Abilify. In addition, Ingenuity Health offers detection tests for other drugs commonly prescribed to treat schizophrenia and bipolar disorder, including Clozaril, Geodon, Haldol, Invega, Zyprexa and Latuda.

Ameritox Appoints Thomas Smith as Chief Medical Officer

Ameritox announced the appointment of Thomas Smith, M.D., as Chief Medical Officer. In this role, Smith will lead a field-based team offering scientific resources for healthcare providers, patients and managed care plans. Smith has held leadership positions at a variety of healthcare companies that have provided him with experiences that will benefit both the pain and behavioral health sides of Ameritox's business. He most recently served as CMO for Mallinckrodt Pharmaceuticals, where he helped the company serve millions of patients around the world with effective and safe medications while helping to quickly grow the company's market capitalization from $2 billion to $8 billion.

Similar Private Companies By Industry

Company Name Region
Medical Group Inc, The United States
Progressive MRI, LLC United States
Granite City Illinois Hospital Company, LLC United States
Health And Palliative Services Of The Treasure Coast, Inc. United States
Healthtrac, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ameritox, Ltd., please visit www.ameritox.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.